POZEN Appoints CMO
This article was originally published in Scrip
POZEN Inc. has appointed Dr James P. Tursi as its chief medical officer. He will also become chief medical officer of Aralez Pharmaceuticals when Aralez, POZEN and Tribute Pharmaceuticals Canada Inc. merge. Most recently Tursi served as chief medical officer of Innocoll AG and prior to joining Innocoll, he was chief medical officer at Auxilium Pharmaceuticals Inc.
Register for our free email digests: